Monoamine oxidases and their inhibitors

Saved in:
Bibliographic Details
Group Author: Riederer P.; (Peter); Youdim Moussa B. H.
Published: Academic Press,
Publisher Address: London
Publication Dates: 2011.
Literature type: Book
Language: English
Series: International Review of Neurobiology, ; v. 100
Subjects:
Carrier Form: xv, 281 p.: ill. ; 24 cm.
ISBN: 9780123864673 (hbk.)
0123864674 (hbk.)
Index Number: R741
CLC: R741.05
Q554.4
Q42
Call Number: Q42/M751
Contents: Includes bibliographical references and index.
Structural properties of human monoamine oxidases A and B -- Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence -- Kinetic behavior and reversible inhibition of monoamine oxidases-enzymes that many want dead -- The pharmacology of selegiline -- Type A monoamine oxidase regulates life and death of neurons in neurodegeneration and neuroprotection -- Multimodal drugs and their future for Alzheimer's and Parkinson's disease -- Neuroprotective profile of hte multitarget drug rasagiline in Parkinson's disease -- Rasagiline in Parkinson's disease -- Selective inhibitors of monamine oxidase type B and the "cheese effect" -- A novel anti-Alzheimer's disase drug, ladostigil: neuroprotective, multimodal brain-selective monamine oxidase and cholinesterase inhibitor -- Novel MAO-B inhibitors: protential therapeutic use of the selective MAO-B inhibitor PF9601N in Parkinson's disease.